Selected research
Market Structure
Global Rosuvastatin Calcium Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Rosuvastatin Calcium Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Rosuvastatin Calcium Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Rosuvastatin Calcium Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Rosuvastatin Calcium Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Rosuvastatin Calcium Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Rosuvastatin Calcium Drug include Accord Healthcare, Actavis Pharma, Angita Pharma, A-S Medication Solutions, AstraZeneca Pharmaceuticals, PD-Rx Pharmaceuticals, Hisun Pharmaceutical, Jinan Jinda and Jingxin Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Rosuvastatin Calcium Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Rosuvastatin Calcium Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Rosuvastatin Calcium Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rosuvastatin Calcium Drug market size, projected growth trends, production technologies, key applications, and end-use industries.
Rosuvastatin Calcium Drug Segment by Company
Accord Healthcare
Actavis Pharma
Angita Pharma
A-S Medication Solutions
AstraZeneca Pharmaceuticals
PD-Rx Pharmaceuticals
Hisun Pharmaceutical
Jinan Jinda
Jingxin Pharmaceutical
Lunan Pharmaceutical Group
Sandoz
Chia-Tai Tianqing Pharmaceutical
Rosuvastatin Calcium Drug Segment by Type
Capsules
Tablets
Rosuvastatin Calcium Drug Segment by Application
Clinics
Hospitals
Others
Rosuvastatin Calcium Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rosuvastatin Calcium Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rosuvastatin Calcium Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rosuvastatin Calcium Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Rosuvastatin Calcium Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rosuvastatin Calcium Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rosuvastatin Calcium Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Rosuvastatin Calcium Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Capsules
- Tablets
Applications
- Clinics
- Hospitals
- Others
Companies covered
- Accord Healthcare
- Actavis Pharma
- Angita Pharma
- A-S Medication Solutions
- AstraZeneca Pharmaceuticals
- PD-Rx Pharmaceuticals
- Hisun Pharmaceutical
- Jinan Jinda
- Jingxin Pharmaceutical
- Lunan Pharmaceutical Group
- Sandoz
- Chia-Tai Tianqing Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Rosuvastatin Calcium Drug Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Rosuvastatin Calcium Drug Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Rosuvastatin Calcium Drug Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Rosuvastatin Calcium Drug Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Rosuvastatin Calcium Drug Market Dynamics
- 2.1 Rosuvastatin Calcium Drug Industry Trends
- 2.2 Rosuvastatin Calcium Drug Industry Drivers
- 2.3 Rosuvastatin Calcium Drug Industry Opportunities and Challenges
- 2.4 Rosuvastatin Calcium Drug Industry Restraints
3 Rosuvastatin Calcium Drug Market by Manufacturers
- 3.1 Global Rosuvastatin Calcium Drug Revenue by Manufacturers (2021-2026)
- 3.2 Global Rosuvastatin Calcium Drug Sales by Manufacturers (2021-2026)
- 3.3 Global Rosuvastatin Calcium Drug Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Rosuvastatin Calcium Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Rosuvastatin Calcium Drug Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Rosuvastatin Calcium Drug Manufacturers, Product Type & Application
- 3.7 Global Rosuvastatin Calcium Drug Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Rosuvastatin Calcium Drug Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Rosuvastatin Calcium Drug Players Market Share by Revenue in 2025
- 3.8.3 2025 Rosuvastatin Calcium Drug Tier 1, Tier 2, and Tier 3
4 Rosuvastatin Calcium Drug Market by Type
- 4.1 Rosuvastatin Calcium Drug Type Introduction
- 4.1.1 Capsules
- 4.1.2 Tablets
- 4.2 Global Rosuvastatin Calcium Drug Sales by Type
- 4.2.1 Global Rosuvastatin Calcium Drug Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Rosuvastatin Calcium Drug Sales by Type (2021-2032)
- 4.2.3 Global Rosuvastatin Calcium Drug Sales Market Share by Type (2021-2032)
- 4.3 Global Rosuvastatin Calcium Drug Revenue by Type
- 4.3.1 Global Rosuvastatin Calcium Drug Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Rosuvastatin Calcium Drug Revenue by Type (2021-2032)
- 4.3.3 Global Rosuvastatin Calcium Drug Revenue Market Share by Type (2021-2032)
5 Rosuvastatin Calcium Drug Market by Application
- 5.1 Rosuvastatin Calcium Drug Application Introduction
- 5.1.1 Clinics
- 5.1.2 Hospitals
- 5.1.3 Others
- 5.2 Global Rosuvastatin Calcium Drug Sales by Application
- 5.2.1 Global Rosuvastatin Calcium Drug Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Rosuvastatin Calcium Drug Sales by Application (2021-2032)
- 5.2.3 Global Rosuvastatin Calcium Drug Sales Market Share by Application (2021-2032)
- 5.3 Global Rosuvastatin Calcium Drug Revenue by Application
- 5.3.1 Global Rosuvastatin Calcium Drug Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Rosuvastatin Calcium Drug Revenue by Application (2021-2032)
- 5.3.3 Global Rosuvastatin Calcium Drug Revenue Market Share by Application (2021-2032)
6 Global Rosuvastatin Calcium Drug Sales by Region
- 6.1 Global Rosuvastatin Calcium Drug Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Rosuvastatin Calcium Drug Sales by Region (2021-2032)
- 6.2.1 Global Rosuvastatin Calcium Drug Sales by Region (2021-2026)
- 6.2.2 Global Rosuvastatin Calcium Drug Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Rosuvastatin Calcium Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Rosuvastatin Calcium Drug Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Rosuvastatin Calcium Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Rosuvastatin Calcium Drug Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Rosuvastatin Calcium Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Rosuvastatin Calcium Drug Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Rosuvastatin Calcium Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Rosuvastatin Calcium Drug Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Rosuvastatin Calcium Drug Revenue by Region
- 7.1 Global Rosuvastatin Calcium Drug Revenue by Region
- 7.1.1 Global Rosuvastatin Calcium Drug Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Rosuvastatin Calcium Drug Revenue by Region (2021-2026)
- 7.1.3 Global Rosuvastatin Calcium Drug Revenue by Region (2027-2032)
- 7.1.4 Global Rosuvastatin Calcium Drug Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Rosuvastatin Calcium Drug Revenue (2021-2032)
- 7.2.2 North America Rosuvastatin Calcium Drug Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Rosuvastatin Calcium Drug Revenue (2021-2032)
- 7.3.2 Europe Rosuvastatin Calcium Drug Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Rosuvastatin Calcium Drug Revenue (2021-2032)
- 7.4.2 Asia-Pacific Rosuvastatin Calcium Drug Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Rosuvastatin Calcium Drug Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Rosuvastatin Calcium Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Accord Healthcare
- 8.1.1 Accord Healthcare Company Information
- 8.1.2 Accord Healthcare Business Overview
- 8.1.3 Accord Healthcare Rosuvastatin Calcium Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Accord Healthcare Rosuvastatin Calcium Drug Product Portfolio
- 8.1.5 Accord Healthcare Recent Developments
- 8.2 Actavis Pharma
- 8.2.1 Actavis Pharma Company Information
- 8.2.2 Actavis Pharma Business Overview
- 8.2.3 Actavis Pharma Rosuvastatin Calcium Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Actavis Pharma Rosuvastatin Calcium Drug Product Portfolio
- 8.2.5 Actavis Pharma Recent Developments
- 8.3 Angita Pharma
- 8.3.1 Angita Pharma Company Information
- 8.3.2 Angita Pharma Business Overview
- 8.3.3 Angita Pharma Rosuvastatin Calcium Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Angita Pharma Rosuvastatin Calcium Drug Product Portfolio
- 8.3.5 Angita Pharma Recent Developments
- 8.4 A-S Medication Solutions
- 8.4.1 A-S Medication Solutions Company Information
- 8.4.2 A-S Medication Solutions Business Overview
- 8.4.3 A-S Medication Solutions Rosuvastatin Calcium Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 A-S Medication Solutions Rosuvastatin Calcium Drug Product Portfolio
- 8.4.5 A-S Medication Solutions Recent Developments
- 8.5 AstraZeneca Pharmaceuticals
- 8.5.1 AstraZeneca Pharmaceuticals Company Information
- 8.5.2 AstraZeneca Pharmaceuticals Business Overview
- 8.5.3 AstraZeneca Pharmaceuticals Rosuvastatin Calcium Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 AstraZeneca Pharmaceuticals Rosuvastatin Calcium Drug Product Portfolio
- 8.5.5 AstraZeneca Pharmaceuticals Recent Developments
- 8.6 PD-Rx Pharmaceuticals
- 8.6.1 PD-Rx Pharmaceuticals Company Information
- 8.6.2 PD-Rx Pharmaceuticals Business Overview
- 8.6.3 PD-Rx Pharmaceuticals Rosuvastatin Calcium Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 PD-Rx Pharmaceuticals Rosuvastatin Calcium Drug Product Portfolio
- 8.6.5 PD-Rx Pharmaceuticals Recent Developments
- 8.7 Hisun Pharmaceutical
- 8.7.1 Hisun Pharmaceutical Company Information
- 8.7.2 Hisun Pharmaceutical Business Overview
- 8.7.3 Hisun Pharmaceutical Rosuvastatin Calcium Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Hisun Pharmaceutical Rosuvastatin Calcium Drug Product Portfolio
- 8.7.5 Hisun Pharmaceutical Recent Developments
- 8.8 Jinan Jinda
- 8.8.1 Jinan Jinda Company Information
- 8.8.2 Jinan Jinda Business Overview
- 8.8.3 Jinan Jinda Rosuvastatin Calcium Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Jinan Jinda Rosuvastatin Calcium Drug Product Portfolio
- 8.8.5 Jinan Jinda Recent Developments
- 8.9 Jingxin Pharmaceutical
- 8.9.1 Jingxin Pharmaceutical Company Information
- 8.9.2 Jingxin Pharmaceutical Business Overview
- 8.9.3 Jingxin Pharmaceutical Rosuvastatin Calcium Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Jingxin Pharmaceutical Rosuvastatin Calcium Drug Product Portfolio
- 8.9.5 Jingxin Pharmaceutical Recent Developments
- 8.10 Lunan Pharmaceutical Group
- 8.10.1 Lunan Pharmaceutical Group Company Information
- 8.10.2 Lunan Pharmaceutical Group Business Overview
- 8.10.3 Lunan Pharmaceutical Group Rosuvastatin Calcium Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Lunan Pharmaceutical Group Rosuvastatin Calcium Drug Product Portfolio
- 8.10.5 Lunan Pharmaceutical Group Recent Developments
- 8.11 Sandoz
- 8.11.1 Sandoz Company Information
- 8.11.2 Sandoz Business Overview
- 8.11.3 Sandoz Rosuvastatin Calcium Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Sandoz Rosuvastatin Calcium Drug Product Portfolio
- 8.11.5 Sandoz Recent Developments
- 8.12 Chia-Tai Tianqing Pharmaceutical
- 8.12.1 Chia-Tai Tianqing Pharmaceutical Company Information
- 8.12.2 Chia-Tai Tianqing Pharmaceutical Business Overview
- 8.12.3 Chia-Tai Tianqing Pharmaceutical Rosuvastatin Calcium Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Chia-Tai Tianqing Pharmaceutical Rosuvastatin Calcium Drug Product Portfolio
- 8.12.5 Chia-Tai Tianqing Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Rosuvastatin Calcium Drug Value Chain Analysis
- 9.1.1 Rosuvastatin Calcium Drug Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Rosuvastatin Calcium Drug Production Mode & Process
- 9.2 Rosuvastatin Calcium Drug Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Rosuvastatin Calcium Drug Distributors
- 9.2.3 Rosuvastatin Calcium Drug Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst